Pafinur (Rupatadine)

Rupatadine, the active ingredient in Pafinur, is an antihistamine presented as a tablet for oral use. It treats allergic rhinitis and chronic urticaria in adults and children over the age of 12. GNH USA supplies Pafinur as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Pafinur as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Rupatadine is an antihistamine that works on the histamine‑mediated allergic pathway. - Allergic rhinitis: reduces nasal congestion, itching and sneezing. - Chronic spontaneous urticaria: lessens wheal formation and itching. - Seasonal allergy symptoms: alleviates eye and throat irritation associated with pollen exposure.

Rupatadine may cause a range of adverse reactions.

Common Side Effects: - Drowsiness: mild to moderate sedation. - Dry mouth: reduced salivation. - Headache: tension‑type headache. - Gastrointestinal discomfort: nausea or mild abdominal pain. - Fatigue: feeling of tiredness.

Serious or Rare Side Effects: - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Anaphylaxis: acute, potentially life‑threatening allergic response. - Cardiac arrhythmias: irregular heart rhythm. - Hepatotoxicity: elevated liver enzymes. - Hematologic abnormalities: thrombocytopenia or neutropenia.

Before using Pafinur, consider the following safety measures: - Assess risk of sedation: patients should avoid driving or operating heavy machinery while experiencing drowsiness. - Review medical history for cardiovascular conditions :   - Evaluate the possible interaction with alcohol :  - Check the presence of renal or the   - Store at below 25°C: keep the tablet in the original pack and protect from moist  -  

Rup ​  

--- ---